Dario Neri

Last Name

Neri

First Name

Dario

ORCID

0000-0001-5234-7370

Organisational unit

01509 - Lehre Chemie u. Ang. Biowiss.

Show all metadata

Search Results

Publications 1 - 10 of 436

A 99m Tc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo
Krall, Nikolaus; Pretto, Francesca; Mattarella, Martin; et al. (2016)
The Journal of Nuclear Medicine
A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies
Berndt, Alexander; Köllner, Robert; Richter, Petra; et al. (2010)
Histochemistry and Cell Biology
Immunoscintigraphy pf patients with head and neck squamous cell carcinomas, with a human anti-angiogenetic antibody fragment
Birchler, M.T.; Thürl, C.; Schmid, D.; et al. (2006)
Otolaryngology - head and neck surgery
Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping
Roesli, Christoph; Mumprecht, Viviane; Neri, Dario; et al. (2008)
The FASEB Journal
Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C
Brack, Simon S.; Silacci, Michela; Birchler, Manfred; et al. (2006)
Clinical Cancer Research
Isolation and characterization of an inhibitory human monoclonal antibody specific to the urokinase-type plasminogen activator, uPA
Sgier, David; Zuberbuehler, Kathrin; Pfaffen, Stefanie; et al. (2010)
Protein Engineering, Design & Selection
Selection of catalytically active biotin ligase and trypsin mutants by phage display
Heinis, Christian; Huber, Adrian; Demartis, Salvatore; et al. (2001)
Protein Engineering
Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes
Gloger, Andreas; Ritz, Danilo; Fugmann, Tim; et al. (2016)
Cancer Immunology, Immunotherapy
Melanoma is one of the most immunogenic tumors, and extensive lists of potential tumor rejection antigens have been collected during the last decades. By isolating human leukocyte antigen (HLA) class I complexes from five melanoma cell lines (FM-82, FM-93/2, Mel-624, MeWo and SK-Mel-5) and sequencing HLA-eluted peptides by mass spectrometry, we identified over 10,000 unique peptides with high confidence. The majority of the peptides were 8–11 amino acids in length and were predicted to bind to the respective HLA alleles. Over 250 epitopes, corresponding to previously described tumor-associated antigens, were identified, suggesting that HLA peptidome analysis may facilitate the characterization of putative tumor rejection antigens. MeWo and SK-Mel-5 cell lines were further interrogated for neo-epitopes, revealing one peptide from MeWo cells carrying an amino acid mutation. We also observed a remarkable overlap between A*03:01 peptides eluted from Mel-624 cells and A*03:01 peptides recovered from soluble HLA complexes purified from two melanoma patients, shedding light on the similarity of the HLA peptidome in cell lines and in patient-derived material. The reliable characterization of the HLA class I peptidome in melanoma promises to facilitate the identification of tumor rejection antigens and the development of immunotherapeutic strategies.
Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes
Nicol, Massimo; Bir, Attila; Cardillo-Piccolino, Felice; et al. (2003)
American Journal of Ophthalmology
A Phase IB Clinical Trial with Dekavil (F8-Il10), an Immunoregulatory 'Armed Antibody' for the Treatment of Rheumatoid Arthritis, Used in Combination with Methotrexate
Galeazzi, M.; Neri, Dario; et al. (2014)
Israel Medical Association Journal

Publications 1 - 10 of 436

Dario Neri

Last Name

First Name

ORCID

Organisational unit

Filters

Search Results